For: | Jiang SY, Chou JM, Leu FJ, Hsu YY, Shih YL, Yu JC, Lee MS, Shyu RY. Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma. World J Gastroenterol 2005; 11(7): 948-953 [PMID: 15742394 DOI: 10.3748/wjg.v11.i7.948] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i7/948.htm |
Number | Citing Articles |
1 |
Lara Costantini, Romina Molinari, Barbara Farinon, Nicolò Merendino. Retinoic Acids in the Treatment of Most Lethal Solid Cancers. Journal of Clinical Medicine 2020; 9(2): 360 doi: 10.3390/jcm9020360
|
2 |
Tzu-Hui Hsu, Chin-Chen Chu, Shun-Yuan Jiang, May-Whey Hung, Wen-Chieh Ni, Huai-En Lin, Tsu-Chung Chang. Expression of the class II tumor suppressor gene RIG1 is directly regulated by p53 tumor suppressor in cancer cell lines. FEBS Letters 2012; 586(9): 1287 doi: 10.1016/j.febslet.2012.03.020
|
3 |
Hongxiang Wang, Hanchong Xu, Tao Xu, Cong Tan, Mei Jiang, Yihong Chen, Xinyu Hu, Jinxu Zhou, Junyan Shen, Rong Qin, Daiyu Hu, Qilin Huang, Min Wang, Lian Wang, Dongxia Duan, Yong Yan, Juxiang Chen. High expression of TIG3 predicts poor survival in patients with primary glioblastoma. Tumor Biology 2017; 39(6): 101042831771213 doi: 10.1177/1010428317712135
|
4 |
Fu-Ming Tsai, Rong-Yaun Shyu, Shun-Yuan Jiang. RIG1 inhibits the Ras/mitogen-activated protein kinase pathway by suppressing the activation of Ras. Cellular Signalling 2006; 18(3): 349 doi: 10.1016/j.cellsig.2005.05.005
|
5 |
Fu-Ming Tsai, Rong-Yaun Shyu, Shun-Yuan Jiang. RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. Cellular Signalling 2007; 19(5): 989 doi: 10.1016/j.cellsig.2006.11.005
|
6 |
Jian-Yong Zhao, Xiang-Kun Yuan, Rui-Zhen Luo, Li-Xin Wang, Wei Gu, Daisuke Yamane, Hui Feng. Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1107239
|
7 |
Suju LUO, Yan ZHENG, Zhenhui PENG, Ju JIANG, Srie GONDOKARYONO, Guorong WANG, Shigaku IKEDA. Effects of narrow‐band ultraviolet B and tazarotene therapy on keratinocyte proliferation and TIG3 expression. The Journal of Dermatology 2008; 35(10): 651 doi: 10.1111/j.1346-8138.2008.00538.x
|
8 |
Orsolya Galamb, Ferenc Sipos, Norbert Solymosi, Sándor Spisák, Tibor Krenács, Kinga Tóth, Zsolt Tulassay, Béla Molnár. Diagnostic mRNA Expression Patterns of Inflamed, Benign, and Malignant Colorectal Biopsy Specimen and their Correlation with Peripheral Blood Results. Cancer Epidemiology, Biomarkers & Prevention 2008; 17(10): 2835 doi: 10.1158/1055-9965.EPI-08-0231
|
9 |
Byeong-Gu Han, Jea-Won Cho, Young-Doo Cho, Soo-Youl Kim, Hye-Jin Yoon, Hyun Kyu Song, Hae-Kap Cheong, Young-Ho Jeon, Dong-ki Lee, Sangho Lee, Byung Il Lee. Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins. Protein Expression and Purification 2010; 71(1): 103 doi: 10.1016/j.pep.2010.01.018
|
10 |
Ji Hu, Fu-ying Zhao, Bin Huang, Jing Ran, Mei-yuan Chen, Hai-lin Liu, You-song Deng, Xia Zhao, Xiao-fan Han. An Eight-CpG-based Methylation Classifier for Preoperative Discriminating Early and Advanced-Late Stage of Colorectal Cancer. Frontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.614160
|
11 |
Nancy E. Ward, Neal R. Pellis, Semyon A. Risin, Diana Risin. Gene expression alterations in activated human T-cells induced by modeled microgravity. Journal of Cellular Biochemistry 2006; 99(4): 1187 doi: 10.1002/jcb.20988
|
12 |
Jun Liu, Yuwei Lu, Yifan Liu, Wei Zhang, Shuyuan Xian, Siqiao Wang, Zixuan Zheng, Ruoyi Lin, Minghao Jin, Mengyi Zhang, Weijin Qian, Jieling Tang, Bingnan Lu, Yiting Yang, Zichang Liu, Mingyu Qu, Haonan Ma, Xinru Wu, Zhengyan Chang, Jie Zhang, Yuan Zhang. A gene signature linked to fibroblast differentiation for prognostic prediction of mesothelioma. Cell & Bioscience 2024; 14(1) doi: 10.1186/s13578-023-01180-7
|
13 |
Fu-Ming Tsai, Rong-Yaun Shyu, Su-Ching Lin, Chang-Chieh Wu, Shun-Yuan Jiang. Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells. BMC Cell Biology 2009; 10(1) doi: 10.1186/1471-2121-10-15
|
14 |
Yan Xu, Ting Chen, Degui Liao, Xiaoqin Wu, Yun Zhong, Shiming Liu, Hui Yang, Yuqiang Nie. The antitumor effect of TIG3 in liver cancer cells is involved in ERK1/2 inhibition. Tumor Biology 2016; 37(8): 11311 doi: 10.1007/s13277-016-4998-x
|
15 |
Shun-Yuan Jiang, Meng-Shiun Wu, Liang-Ming Chen, Mei-Whey Hung, Huai-En Lin, Gu-Gang Chang, Tsu-Chung Chang. Identification and characterization of the retinoic acid response elements in the human RIG1 gene promoter. Biochemical and Biophysical Research Communications 2005; 331(2): 630 doi: 10.1016/j.bbrc.2005.03.214
|
16 |
Chang-Chieh Wu, Rong-Yaun Shyu, Jung-Mao Chou, Shu-Wen Jao, Pei-Chieh Chao, Jung-Cheng Kang, Sheng-Tang Wu, Shiang-Long Huang, Shun-Yuan Jiang. RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. European Journal of Cancer 2006; 42(4): 557 doi: 10.1016/j.ejca.2005.11.015
|